Primary Faculty: Cancer Biology
Yong Q. Chen, PhD My research focuses on two areas of prostate cancer; (1) genetic basis and lipid signaling in prostate cancer development, and (2) effect of dietary fat on prostate cancer development in genetically predisposed populations. Faculty Page Laboratory Page
William H. Gmeiner, PhD, MBA Research in my laboratory is focused on developing novel cytotoxic oligodeoxynucleotides (ODNs) for treatment of prostate cancer and other malignancies and in understanding the role of DNA structure in carcinogenesis and cancer chemotherapy. Faculty Page Laboratory Page
Zhennan Gu, PhD Faculty Page
Steven Kridel, PhD Research in my lab focuses on understanding the regulation of pathways that control fatty acid synthesis by fatty acid synthase in prostate cancer. Faculty Page Laboratory Page
George Kulik, PhD My laboratory is focusing on signal transduction mechanisms that protect prostate cancer cells from apoptosis. This information is necessary to design more effective therapies for advanced prostate cancer and other therapy resistant cancers. Faculty Page Laboratory Page
Lance D. Miller, PhD Using genomic technologies such as DNA microarrays, my laboratory investigates the transcriptional dynamics and genomic architectures of primary tumors to uncover novel prognostic biomarkers and mechanisms of disease progression. Faculty Page Laboratory Page
Mark Miller, PhD Research in my laboratory is examining environmental/genetic interactions that affect an organism’s susceptibility to lung cancer formation, utilizing a variety of in vivo models and molecular biological techniques. Faculty Page Laboratory Page
Gary G. Schwartz, PhD, MPH, PhD We have suggested that the descriptive epidemiology of prostate cancer, i.e., the increasing risk with age, Black race, and residence at northern latitudes, resemble the descriptive epidemiology of vitamin D deficiency in the elderly. Faculty Page Laboratory Page
Darren F. Seals, PhD Our lab is interested in the basic mechanisms of cell migration and invasion, particularly as it relates to tumor growth and metastasis. Faculty Page Laboratory Page
Ravi Singh, PhD The focus of my research is the integration of specific clinical applications into the development of nanotechnology-based, multifunctional units designed to diagnose cancer, deliver therapeutic agents, and monitor cancer treatment (so called “theranostic” agents). Faculty Page Laboratory Page
Guangchao Sui, PhD The research in our lab focuses on the molecular mechanisms of the epigenetic regulation of tumorigenesis. Faculty Page Laboratory Page
Jim Vaughn, PhD The Vaughn laboratory is focused on assaying the anti-tumor therapeutic potential of new classes of chemically modified DNA oligonucleotides. Faculty Page Laboratory Page
Thad Wadas, PhD Our research program utilizes the tools of molecular biology, chemistry and radiochemistry to develop targeted agents for cancer detection and therapy. Faculty Page Laboratory Page
Shihua Wang, PhD Faculty Page